Pulmonary Disease Doctors in Olathe, KS Accepting Medicare

7 Pulmonary Disease doctors found. Showing 1 - 7

Dr. Everett Middleton Murphy Iii, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 20375 W 151st St, Suite 451, Olathe, KS 66061 Phone: 913-829-0446    Fax: 913-829-7829

Dominique M Crain, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 20375 W 151st St, 451, Olathe, KS 66061 Phone: 913-829-0446

Dr. Vance Reid Burns, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 20375 W 151st St, The Doctors Building One, Suite 451, Olathe, KS 66061 Phone: 913-829-0446    Fax: 913-829-7829

Matthew Thomas Mcleay, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 20375 W 151st St Ste 451, Olathe, KS 66061 Phone: 913-829-0446    Fax: 913-829-7829

Dr. Dennis Paul Lawlor, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 20375 W 151st St, Suite 451, Olathe, KS 66061 Phone: 913-829-0446    Fax: 913-829-7829

Najla N Maalouf, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 20375 W 151st St, 451, Olathe, KS 66061 Phone: 913-829-0446    Fax: 913-829-0446

Dr. James Keith Bradley, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 20375 W 151st St, Suite 451, Olathe, KS 66061 Phone: 913-829-0446    Fax: 913-829-7829

News Archive

Researchers develop novel method to store microfluidic devices for CD4 T cell testing

Providing vital health care services to people in developing countries without reliable electricity, refrigeration and state-of-the-art medical equipment poses a number of challenges. Inspired by pregnancy tests, researchers from Florida Atlantic University, Stanford University, and Baskent University in Turkey, have developed a novel method to store microfluidic devices for CD4 T cell testing in extreme weather conditions for up to six months without refrigeration.

FDA approval of Pipeline Embolization Device offers better options for treatment of large/giant aneurysms

The recent U.S. Food and Drug Administration (FDA) approval of a brain aneurysm device has opened the door for neurosurgeons at Jefferson Hospital for Neuroscience (JHN) to offer advanced treatment to patients suffering from large or giant aneurysms who otherwise have limited, effective options.

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced that the China National Medical Products Administration approved the kinase inhibitor LENVIMA (lenvatinib) as a single agent for the treatment of patients with unresectable hepatocellular carcinoma who have not received prior systemic therapy.

New data reveals safety, efficacy of nusinersen drug delivery method for SMA patients with advanced disease

A recently published paper details the safety and efficacy of nusinersen administration via a subcutaneous intrathecal catheter system (SIC) for SMA patients with advanced disease.

NIH awards Clinical and Translational Science Award to three Texas Medical Center institutions

In 2006, three Texas Medical Center institutions were among the first in the nation to receive a Clinical and Translational Science Award (CTSA) from the National Institutes of Health (NIH) to accelerate the translation of laboratory discoveries into patient treatments. That grant has been renewed for another 5 years.

Read more Medical News

› Verified 7 days ago